.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 005264

« Back to Dashboard
NDA 005264 describes PANHEPRIN, which is a drug marketed by Hospira and is included in one NDA. It is available from one supplier. Additional details are available on the PANHEPRIN profile page.

The generic ingredient in PANHEPRIN is heparin sodium. There are seventy-five drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.

Summary for NDA: 005264

Tradename:
HEPARIN LOCK FLUSH
Applicant:
Hospira
Ingredient:
heparin sodium
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 005264

Ingredient-typeHeparin

Suppliers and Packaging for NDA: 005264

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HEPARIN LOCK FLUSH
heparin sodium
INJECTABLE;INJECTION 005264 NDA General Injectables & Vaccines, Inc 52584-151 52584-151-78 1 VIAL, MULTI-DOSE in 1 BAG (52584-151-78) > 30 mL in 1 VIAL, MULTI-DOSE
HEPARIN SODIUM PRESERVATIVE FREE
heparin sodium
INJECTABLE;INJECTION 005264 NDA General Injectables & Vaccines, Inc 52584-151 52584-151-78 1 VIAL, MULTI-DOSE in 1 BAG (52584-151-78) > 30 mL in 1 VIAL, MULTI-DOSE

Summary for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength1,000 UNITS/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 006

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength5,000 UNITS/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 007

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength10,000 UNITS/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc